ASX Small Cap Lunch Wrap: Who’s dicing with the devil today?
Link copied to
If you have a passing interest in rituals, watch the final few seconds of this video, which includes a clip of some sort of satanic rite:
— Media Watch (@ABCmediawatch) August 19, 2021
As the ABC’s own MediaWatch asks; what was going on there?
It’s a good question, but either way a few Twitter conspiracy theorists are already having a field day over it….
Despite the plunge in iron ore prices overnight, the ASX 200 is holding up and is up by 0.20% heading into the midday trading.
Materials sector was the main laggard, down by 1%, while Consumer Staples led the pack at half time, up by 1.8%.
Treasury Wine Estates (ASX:TWE) over-performed the Staples, rising by 5%. There was no news on TWE today, but yesterday the company had announced a $250 million in profits and declared a final dividend of 13c a share.
Overnight, the iron ore price tumbled by 13.5% to $US132.66 a tonne, on demand concerns from China. The iron ore spot price has now tumbled by 45% from its highs in May.
Meanwhile, the ASX Emerging Companies Index (XEC) has dropped by 1.2% at midday.
Here are the best performing ASX small cap stocks for August 20 [intraday]:
Swipe or scroll to reveal full table. Click headings to sort:
Iceni Gold (ASX:ICL) is up by 20% after announcing the issuance of new ICL shares at 22.5c as part of its $2.025m capital raising to fund the drilling campaign at the Deep Well Target in WA.
Cybersecurity company WhiteHawk (ASX:WHK) rose 15% on no news. However, the company announced yesterday that it had renewed its contract with the US Federal Government for US$608k, with an option for additional US$505k.
Nagambie Resources (ASX:NAG) rose 11% after saying that it has received a permit for its Nagambie Gold Mine in Victoria.
Potash and iron ore miner BCI Minerals (ASX:BCI), climbed almost 6% after reporting a full year group NPAT of $22m, which is a substantial increase from the $4m profit reported in FY20.
Chimeric Therapeutics (ASX:CHM) climbed 5% after announcing that it has received received IND (investigational new drug) clearance from the US FDA for CHM 1101 (CLTX CAR T) for treating glioblastoma.
Financial company MyState (ASX:MYS) rose 3.5% on solid earnings. MYS reported a 20.9% increase in NPAT to $36.3m for the full year of FY21.
Here are the worst performing ASX small cap stocks for August 20 [intraday]:
IoT and smart home specialist Zimi (ASX:ZMM) fell by 11% after raising $3.85m in institutional placements at 1.5c a share.